L. Portugal

838 total citations
13 papers, 551 citations indexed

About

L. Portugal is a scholar working on Surgery, Otorhinolaryngology and Oncology. According to data from OpenAlex, L. Portugal has authored 13 papers receiving a total of 551 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Surgery, 11 papers in Otorhinolaryngology and 9 papers in Oncology. Recurrent topics in L. Portugal's work include Head and Neck Cancer Studies (11 papers), Head and Neck Surgical Oncology (10 papers) and Lung Cancer Research Studies (6 papers). L. Portugal is often cited by papers focused on Head and Neck Cancer Studies (11 papers), Head and Neck Surgical Oncology (10 papers) and Lung Cancer Research Studies (6 papers). L. Portugal collaborates with scholars based in United States and Argentina. L. Portugal's co-authors include Everett E. Vokes, Daniel J. Haraf, Barry L. Wenig, Kerstin Stenson, M.E. Witt, Alfred Rademaker, Harold J. Pelzer, Bruce Brockstein, Ralph Weichselbaum and Bing B Fung and has published in prestigious journals such as Journal of Clinical Oncology, International Journal of Radiation Oncology*Biology*Physics and Annals of Oncology.

In The Last Decade

L. Portugal

12 papers receiving 544 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
L. Portugal United States 5 431 313 180 159 63 13 551
Ngian‐Chye Tan Singapore 9 174 0.4× 257 0.8× 77 0.4× 84 0.5× 27 0.4× 12 357
J.A. Marks United States 3 399 0.9× 228 0.7× 208 1.2× 149 0.9× 44 0.7× 5 576
Denis Langlois France 8 211 0.5× 255 0.8× 100 0.6× 149 0.9× 12 0.2× 16 378
Frank Worden United States 8 624 1.4× 301 1.0× 383 2.1× 124 0.8× 74 1.2× 21 817
B. Géry France 9 367 0.9× 287 0.9× 164 0.9× 156 1.0× 24 0.4× 23 471
Phyllis Ager Mowry United States 9 292 0.7× 460 1.5× 394 2.2× 251 1.6× 29 0.5× 9 713
Sandro Tonoli Italy 8 215 0.5× 148 0.5× 232 1.3× 102 0.6× 43 0.7× 22 394
H.-J. Thiel Germany 7 471 1.1× 379 1.2× 259 1.4× 207 1.3× 42 0.7× 15 630
Sai Ki O China 7 319 0.7× 243 0.8× 191 1.1× 151 0.9× 23 0.4× 8 441
Wojciech Majewski Poland 12 57 0.1× 139 0.4× 144 0.8× 83 0.5× 44 0.7× 56 340

Countries citing papers authored by L. Portugal

Since Specialization
Citations

This map shows the geographic impact of L. Portugal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L. Portugal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L. Portugal more than expected).

Fields of papers citing papers by L. Portugal

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L. Portugal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L. Portugal. The network helps show where L. Portugal may publish in the future.

Co-authorship network of co-authors of L. Portugal

This figure shows the co-authorship network connecting the top 25 collaborators of L. Portugal. A scholar is included among the top collaborators of L. Portugal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L. Portugal. L. Portugal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Rosenberg, Ari J., Nishant Agrawal, Elizabeth A. Blair, et al.. (2021). 867P A phase I trial of nab-paclitaxel-based induction followed by nab-paclitaxel-based concurrent chemotherapy and re-irradiation in previously treated head and neck squamous cell carcinoma. Annals of Oncology. 32. S790–S790. 2 indexed citations
2.
Foster, Corey C., Tanguy Y. Seiwert, Ellen MacCracken, et al.. (2019). Dose and Volume De-Escalation for HPV-Positive Oropharyngeal Cancer is Associated with Favorable Post-Treatment Functional Outcomes. International Journal of Radiation Oncology*Biology*Physics. 105(1). E419–E419. 1 indexed citations
3.
Seiwert, Tanguy Y., Corey C. Foster, Elizabeth A. Blair, et al.. (2018). OPTIMA: a phase II dose and volume de-escalation trial for human papillomavirus-positive oropharyngeal cancer. Annals of Oncology. 30(2). 297–302. 149 indexed citations
4.
Seiwert, Tanguy Y., J.M. Melotek, Corey C. Foster, et al.. (2018). OPTIMA—A Phase 2 Trial of Induction Chemotherapy Response-Stratified Radiation Therapy Dose and Volume De-escalation for HPV+ Oropharyngeal Cancer: Efficacy, Toxicity, and HPV Subtype Analysis. International Journal of Radiation Oncology*Biology*Physics. 100(5). 1309–1309. 3 indexed citations
5.
Melotek, J.M., Tanguy Y. Seiwert, Elizabeth A. Blair, et al.. (2017). A Phase 2 Dose and Volume De-escalation Trial for High- and Low-Risk HPV+ Oropharynx Cancer: Efficacy, Toxicity, and Dosimetric Analyses. International Journal of Radiation Oncology*Biology*Physics. 99(2). S135–S135. 2 indexed citations
6.
Villaflor, Victoria, J.M. Melotek, Theodore Karrison, et al.. (2016). Response-adapted volume de-escalation (RAVD) in locally advanced head and neck cancer. Annals of Oncology. 27(5). 908–913. 69 indexed citations
7.
Melotek, J.M., Victoria Villaflor, Theodore Karrison, et al.. (2016). Response-Adapted Volume De-escalation (RAVD) in Locally Advanced Head and Neck Cancer: Efficacy and Human Papillomavirus–Positive Subgroup Analysis. International Journal of Radiation Oncology*Biology*Physics. 94(4). 865–865. 2 indexed citations
8.
Melotek, J.M., Victoria Villaflor, Theodore Karrison, et al.. (2016). Updated Results From a Phase 1/Randomized Phase 2 Trial of Response-Adapted Volume De-escalation (RAVD) for Locally Advanced Head and Neck Cancer. International Journal of Radiation Oncology*Biology*Physics. 96(2). S219–S219.
9.
Melotek, J.M., Victoria Villaflor, Ryan J. Brisson, et al.. (2015). Response-Adapted Volume Deescalation (RAVD) in Locally Advanced Head and Neck Squamous Cell Cancer (LA-HNSCC): Toxicity and Quality of Life (QOL) Analyses. International Journal of Radiation Oncology*Biology*Physics. 93(3). E335–E335. 2 indexed citations
10.
Villaflor, Victoria, Daniel J. Haraf, Joseph K. Salama, et al.. (2011). Phase II trial of pemetrexed-based induction chemotherapy followed by concomitant chemoradiotherapy in previously irradiated patients with squamous cell carcinoma of the head and neck. Annals of Oncology. 22(11). 2501–2507. 16 indexed citations
11.
Villaflor, Victoria, Ezra E.W. Cohen, D. Haraf, et al.. (2008). Phase II trial pemetrexed-based induction chemotherapy followed by concomitant chemoradiotherapy in previously irradiated head and neck cancer patients. Journal of Clinical Oncology. 26(15_suppl). 6030–6030. 1 indexed citations
12.
Brockstein, Bruce, Daniel J. Haraf, Alfred Rademaker, et al.. (2004). Patterns of failure, prognostic factors and survival in locoregionally advanced head and neck cancer treated with concomitant chemoradiotherapy: a 9-year, 337-patient, multi-institutional experience. Annals of Oncology. 15(8). 1179–1186. 265 indexed citations
13.
Portugal, L., et al.. (1997). Negative-pressure pulmonary edema in the otolaryngology patient. Otolaryngology. 117(1). 62–66. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ngian‐Chye Tan Breakdown of academic impact, for papers by J.A. Marks Breakdown of academic impact, for papers by Denis Langlois Breakdown of academic impact, for papers by Frank Worden Breakdown of academic impact, for papers by B. Géry Breakdown of academic impact, for papers by Phyllis Ager Mowry Breakdown of academic impact, for papers by Sandro Tonoli Breakdown of academic impact, for papers by H.-J. Thiel Breakdown of academic impact, for papers by Sai Ki O Breakdown of academic impact, for papers by Wojciech Majewski
Rankless by CCL
2026